Ursodeoxycholic acid for most patients with primary biliary cirrhosis Newsletter Article 15 February 2013 Pages: 4 - 4
Drugs for personality disorder gain some respectability Newsletter Article 15 February 2013 Pages: 4 - 4
No strong evidence to support ‘polypharmacy’ in Parkinson’s disease Newsletter Article 15 February 2013 Pages: 5 - 5
Maintenance therapy with sertraline ‘a cost-effective strategy’ Newsletter Article 15 February 2013 Pages: 7 - 7
Total malaria eradication - are we any closer? Lori Bonertz Newsletter Article 15 February 2013 Pages: 9 - 10
A ‘refreshingly different approach’ using monoclonal antibodies Newsletter Article 15 February 2013 Pages: 11 - 11
Anti-inflammatory agents in sepsis - ‘more complex than first believed’ Newsletter Article 15 February 2013 Pages: 12 - 12
Granisetron superior to metoclopramide postoperatively Newsletter Article 15 February 2013 Pages: 13 - 13
Interferon-γ adds to treatment of mycobacterial infections Newsletter Article 15 February 2013 Pages: 13 - 13
‘Socially disadvantaged’ receive more psychotropics Newsletter Article 15 February 2013 Pages: 13 - 13
Significantly more rapid gastric ulcer healing with lansoprazole Newsletter Article 15 February 2013 Pages: 14 - 14
No additional survival with intensive chemotherapy in NHL Newsletter Article 15 February 2013 Pages: 15 - 15
H. pylori eradication - cost-effective for duodenal and gastric ulceration Newsletter Article 15 February 2013 Pages: 16 - 16
Low-dose indomethacin in very-low-birthweight neonates Newsletter Article 15 February 2013 Pages: 16 - 16
Role of pharmacokinetic-pharmacodynamic modelling in drug development Lee Barradell Newsletter Article 15 February 2013 Pages: 19 - 19